You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 53 No. 5, May 1955 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on Web of Science (6)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Intravenous Treatment of Optic Neuritis

Comparison of Corticotropin and Typhoid Bacilli

PHILIP KAZDAN, M.D.; ROSCOE J. KENNEDY, M.D.

AMA Arch Ophthalmol. 1955;53(5):700-701.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

There are many reports in the current literature on the intravenous use of corticotropin and of typhoid; however, there are no articles comparing their clinical use in ophthalmology. This study was undertaken in order to ascertain the clinical value of intravenous corticotropin (ACTH; adrenocorticotropic hormone) in comparison with that of intravenous killed typhoid bacilli in the treatment of optic neuritis: We have compared the results of treatment in two groups of patients, one in which the treatment was with corticotropin and the other in which it was with killed typhoid bacilli.

It has been shown by Olson and associates1 that nonspecific foreign protein, i. e., killed typhoid organisms, among other drugs, produces changes in the adrenal cortex which are characteristic of the general response to stress, and that the benefit derived from this form of therapy could be attributed to the release of endogenous adrenocorticotropic hormone.* The same type . . . [Full Text PDF of this Article]


Author Affiliations

Cleveland

From the Department of Ophthalmology, The Cleveland Clinic Foundation, and The Frank E. Bunts Educational Institute.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1955 American Medical Association. All Rights Reserved.